Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin Pharmacol Ther. 2003 Oct; 74(4):388-400.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
British Columbia
Calcium Channel Blockers
Cost Sharing
Costs and Cost Analysis
Dihydropyridines
Drug Costs
Female
Health Services for the Aged
Humans
Income
Male
Pharmacoepidemiology
authors with profiles
Sebastian Schneeweiss, Sc.D., M.D.
Stephen Bertram Soumerai, Sc.D.
Robert James Glynn, Sc.D., Ph.D.
Alec Walker, D.P.H., M.D.